Back to VYNE
CITADEL ADVISORS LLC VYNE Position History
VYNE Therapeutics Inc • Healthcare
Quarters held
15
Latest value
$305K
Q2 2026
Peak value
$4M
First seen
Q4 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2023 | $2.8M |
| Q1 2024 | $3.6M |
| Q2 2024 | $2.3M |
| Q2 2024 | $59K |
| Q3 2024 | $2.2M |
| Q3 2024 | $12K |
| Q4 2024 | $4M |
| Q4 2024 | $165K |
| Q1 2025 | $1.6M |
| Q1 2025 | $95K |
| Q2 2025 | $1.7M |
| Q4 2025 | $18K |
| Q1 2026 | $307K |
| Q2 2026 | $305K |
| Q2 2026 | $305K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $305K | 468.5K | — | — |
| Q2 2026 | $305K | 468.5K | — | — |
| Q1 2026 | $307K | 514.4K | — | — |
| Q4 2025 | $18K | 30.5K | — | — |
| Q2 2025 | $1.7M | 1.04M | — | — |
| Q1 2025 | $95K | 60.3K | — | — |
| Q1 2025 | $1.6M | 1.04M | — | — |
| Q4 2024 | $165K | 49.4K | — | — |
| Q4 2024 | $4M | 1.18M | — | — |
| Q3 2024 | $12K | 6.3K | — | — |
| Q3 2024 | $2.2M | 1.18M | — | — |
| Q2 2024 | $59K | 30.0K | — | — |
| Q2 2024 | $2.3M | 1.18M | — | — |
| Q1 2024 | $3.6M | 1.18M | — | — |
| Q4 2023 | $2.8M | 1.18M | — | — |